Addressing Psychological Distress After Venous Thromboembolism
Researchers are seeking to address the psychological impact of patients who have survived VTE.
Researchers are seeking to address the psychological impact of patients who have survived VTE.
Barney Stern, MD, and Andrew Russman, DO, share how the COVID-19 pandemic has changed neurology practice, including patient access to care, staffing shortages, and increased burnout.
Cardiovascular disease remains a leading cause of death among breast cancer survivors.
We interview experts Younghoon Kwon, MD, MS, FACC, and Richard J Castriotta, MD, FCCP, FAASM, about the connections between obstructive sleep apnea-sudden cardiac death.
Researchers sought to highlight several recent advances in the epidemiology, pathogenesis, clinical features, investigation, acute management, and secondary prevention of cerebrovascular diseases in patients with hematological diseases.
Experts discuss how clinicians, healthcare leaders, and payers can prioritize incorporating cardiac rehabilitation as part of the standard of care for patients with heart failure.
In this interview, Richard Becker, MD, gives us an insight into COVID-19 vasculitis and its manifestations.
The 6th WSPH Task Force on Hemodynamic Definitions and Clinical Classification recently proposed reducing the diagnostic mPAP threshold for pulmonary hypertension.
Despite substantial advances in therapeutic options for HFrEF, significant gaps remain in the use of guideline-directed medical therapy in these patients.
Mechanistic and outcomes studies are warranted to elucidate the lipid paradox and CVD risk in rheumatoid arthritis (RA).